By www.marketscagr.com
Global Klebsiella Pneumoniae Infection Drug Market Insights And Forecast To 2031 Story
111
$ 4900
Klebsiella Pneumoniae Infection Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Acies Bio doo
Appili Therapeutics
Debiopharm International SA
Evaxion Biotech ApS
F. Hoffmann-La Roche Ltd
FOB Synthesis Inc
ImmunoClin Corp
Innovation Pharmaceuticals Inc
Kyorin Pharmaceutical Co Ltd
Melinta Therapeutics Inc
Nosopharm SAS
Peptilogics Inc
Pfizer Inc
Phico Therapeutics Ltd
Sarepta Therapeutics Inc
Shionogi & Co Ltd
Syntiron LLC
Tetraphase Pharmaceuticals Inc